China's import of pacemakers for stimulating heart muscles is forecasted to grow steadily from 2024 to 2028, with values rising from 116.43 to 128.92 thousand units per year. This indicates a consistent year-on-year increase of approximately 2.6% to 2.9% annually. The forecast projects a compound annual growth rate (CAGR) of around 2.6% for this five-year period.
In 2023, prior to these forecasts, the market showed smaller growth percentages, reflecting growing demand due to increased awareness of cardiovascular health and the aging population in China.
Future trends to watch for include technological advancements in pacemaker technology and changes in healthcare policies that may affect imports. Additionally, monitoring global supply chain dynamics and potential trade agreements will be crucial for market stakeholders.
